CYTOTOXIC T-LYMPHOCYTE ANTIGEN-4 OR INTERLEUKIN-10 POLYMORPHISMS AS PREDICTORS OF RESPONSE TO THERAPEUTIC INTERVENTION

Details for Australian Patent Application No. 2002306617 (hide)

Owner UAB RESEARCH FOUNDATION

Inventors YEE, Leland; TANG, Jianming; KASLOW, Richard, A.; VAN LEEUWEN, Dirk J.

Pub. Number AU-A-2002306617

PCT Number PCT/US02/06207

PCT Pub. Number WO2002/068699

Priority 60/271,811 27.02.01 US

Filing date 27 February 2002

Wipo publication date 12 September 2002

International Classifications

C12Q 001/70 Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 039/29 Medicinal preparations containing antigens or antibodies - Hepatitis virus

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/271,811 27.02.01 US

6 March 2003 Application Open to Public Inspection

  Published as AU-A-2002306617

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002306618-Substituted diarylureas as stimulators for Fas-mediated apoptosis

2002306616-COMPOSITIONS AND METHODS FOR MANAGEMENT OF SEROTONIN-MEDIATED DISORDERS